Mohammed Elmourtada Abdulgayoom։ Caplacizumab-Enabled Treatment of iTTP Without Plasma Exchange
Mohammed Elmourtada Abdulgayoom, Clinical Hematology Specialist at Hamad Medical Corporation, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Clinical and Applied Thrombosis/Hemostasis, adding։
”I’m pleased to share our new publication in Clinical and Applied Thrombosis/Hemostasis:
‘Caplacizumab-Enabled Treatment of Immune-Mediated Thrombotic Thrombocytopenic Purpura Without Plasma Exchange: Evidence, Patient Selection, and Practical Considerations.’
In this narrative review, we examine the evolving evidence for caplacizumab-based, plasma exchange–free management of immune-mediated TTP.
This approach may be feasible in carefully selected, clinically stable patients when combined with adequate immunosuppression, close ADAMTS13 monitoring, assessment of the early platelet response, and immediate access to rescue plasma exchange when required.
Many thanks to my co-authors Nabeel Qasem, Yousef Al-Asa’d, Awni Alshurafa, and Mohamed Yassin for their valuable collaboration and contributions.”
Title: Caplacizumab-Enabled Treatment of Immune-Mediated Thrombotic Thrombocytopenic Purpura Without Plasma Exchange: Evidence, Patient Selection, and Practical Considerations
Authors: Nabeel Qasem, Yousef Al-Asa’d, Mohammed Abdulgayoom, Awni Alshurafa, Mohamed Yassin
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 21, 2026, 00:29Iheanyichukwu Ike: Childhood Anaemia in Nigeria Through an Analysis of the 2018 NDHS
-
Sep 21, 2026, 00:27Nicole De Vita: The Global Burden of Iron Deficiency and Anemia in Women at SABM
-
Sep 21, 2026, 00:25Giuseppe Panuccio: IVUS and OCT Guidance Reduce MACE and Stent Thrombosis in Calcified Coronary Lesions
-
Sep 21, 2026, 00:23Parveen Yograj: Anemia in Older Adults 2026 – Don’t Call It “Just Old Age” and Find the Cause
-
Sep 21, 2026, 00:22Peter A. McCullough: McCullough Protocol Base Spike Detoxification and Oral Anticoagulation for Athletes
-
Sep 21, 2026, 00:20Rolando Claure: Apixaban Shows a More Favorable Benefit Risk Balance in Advanced CKD With AF
-
Sep 21, 2026, 00:14Kathaleen Schnur: HCWP’s Bubble Brigade at the 2026 Unite for Bleeding Disorders Walk
-
Sep 21, 2026, 00:13Amr Abouleish: Jehovah’s Witnesses Announce That Accepting Blood Is a Matter of Personal Conscience
-
Sep 21, 2026, 00:08Oluseyi Victor Owoeye: The Importance of Respecting Clients’ Beliefs, Values, Autonomy, and Human Dignity